Antonia Netzl

MedicineAgricultural and Biological SciencesBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

2.3Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Combining antigenic data from public sources gives an early indication of the immune escape of emerging virus variants

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2021.12.31.474032

Top 12%

1.7DataRank

Top 12%29 citations

Sina Türeli, Eric B. LeGresley, Barbara Mühlemann, Samuel Wilks, Derek J. Smith +1 more

Papers

Driven by 23 papers — median percentile 64. Top paper: “Defining the risk of SARS-CoV-2 variants on immune protection”.

Defining the risk of SARS-CoV-2 variants on immune protection

Nature(2022)10.1038/s41586-022-04690-5

N/A

4.9DataRank · unranked

185 citations

Elodie Ghedin, Matthew B. Frieman, Florian Krammer, Alba Grifoni, Arghavan Alisoltani +95 more

Combining antigenic data from public sources gives an early indication of the immune escape of emerging virus variants

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2021.12.31.474032

Top 12%

1.7DataRank

Top 12%29 citations

Sina Türeli, Eric B. LeGresley, Barbara Mühlemann, Samuel Wilks, Derek J. Smith +1 more

SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses

medRxiv(2022)10.1101/2022.07.12.22277336

N/A

1.6DataRank · unranked

30 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +63 more

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

Nature Medicine(2023)10.1038/s41591-023-02503-4

N/A

1.3DataRank · unranked

56 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +94 more

Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays

Science Translational Medicine(2024)10.1126/scitranslmed.adl1722

Top 36%

0.541DataRank

Top 36%15 citations

Samuel Wilks, Lauren Baracco, Meriem Bekliz, Juan Manuel Carreño, Victor M. Corman +41 more

Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial

Research Square(2023)10.21203/rs.3.rs-2653179/v1

N/A

0.372DataRank · unranked

5 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +63 more

Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost

Nature Communications(2025)10.1038/s41467-025-55931-w

N/A

0.345DataRank · unranked

9 citations

Youyi Fong, Lauren Dang, Jonathan Fintzi, Shiyu Chen, Jing Wang +43 more

Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.27.559689

N/A

0.301DataRank · unranked

4 citations

Samuel Wilks, Lauren Baracco, Meriem Bekliz, Juan Manuel Carreño, Victor M. Corman +41 more

Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography

medRxiv(2023)10.1101/2023.05.02.23289412

N/A

0.269DataRank · unranked

5 citations

Antonia Netzl, Ludwig Knabl, David Bante, Samuel Wilks, Wegene Borena +4 more

Durability of Cross-Neutralizing Antibodies 5.5 Months After Bivalent Coronavirus Disease 2019 Vaccine Booster

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad472

N/A

0.165DataRank · unranked

2 citations

Ludwig Knabl, Antonia Netzl, David Bante, Wegene Borena, Dorotheé von Laer +3 more

Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial

medRxiv(2023)10.1101/2023.01.31.23285306

N/A

0.104DataRank · unranked

1 citations

Nadine Rouphael, Cecilia Losada, Lindsey R. Baden, Evan J. Anderson, Anne F. Luetkemeyer +31 more

Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography

Nature Communications(2023)10.1038/s41467-023-41049-4

N/A

0DataRank · unranked

45 citations

Antonia Netzl, Ludwig Knabl, David Bante, Samuel Wilks, Wegene Borena +4 more

Mapping SARS-CoV-2 antigenic relationships and serological responses

Science(2023)10.1126/science.adj0070

N/A

0DataRank · unranked

135 citations

Barbara Mühlemann, Xiaoying Shen, Sina Türeli, Eric B. LeGresley, Antonia Netzl +27 more

Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial

medRxiv(2023)10.1101/2023.06.06.23290973

N/A

0DataRank · unranked

0 citations

Angela R Branche, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +31 more

Mapping SARS-CoV-2 antigenic relationships and serological responses

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.28.477987

N/A

0DataRank · unranked

67 citations

Barbara Mühlemann, Xiaoying Shen, Sina Türeli, Eric B. LeGresley, Antonia Netzl +27 more

Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera

npj Vaccines(2024)10.1038/s41541-024-00888-y

N/A

0DataRank · unranked

9 citations

Antonia Netzl, Ludwig Knabl, Samuel Wilks, Barbara Mühlemann, Sina Türeli +6 more

Defining the risk of SARS-CoV-2 variants on immune protection

UNC Libraries(2024)10.17615/ztqb-8n94

N/A

0DataRank · unranked

0 citations

Boritz E.A., Sinai Sacharen, VanBlargan L.A., Liebeskind M.J., Wei Wang +95 more

Exposure to two antigenically distinct SARS-CoV-2 variants broadens neutralization patterns

Vaccine(2025)10.1016/j.vaccine.2025.127459

N/A

0DataRank · unranked

6 citations

Annika Rössler, Antonia Netzl, Ludwig Knabl, Albert Falch, Patrick Neckermann +9 more

Nonhuman primate antigenic cartography of SARS-CoV-2

Cell Reports(2025)10.1016/j.celrep.2024.115140

N/A

0DataRank · unranked

13 citations

Antonia Netzl, Ninaad Lasrado, Jayeshbhai Chaudhari, Barbara Mühlemann, Samuel Wilks +4 more

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants

Nature Communications(2022)10.1038/s41467-022-35312-3

N/A

0DataRank · unranked

90 citations

Antonia Netzl, Ludwig Knabl, Helena Schäfer, Samuel Wilks, David Bante +6 more

Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad323

N/A

0DataRank · unranked

3 citations

Angela R Branche, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +80 more

Combining antigenic data from public sources gives an early indication of the immune escape of emerging virus variants

Scientific Reports(2025)10.1038/s41598-025-19578-3

Top 100%

0DataRank

Top 100%0 citations

Sina Türeli, Eric B. LeGresley, Barbara Mühlemann, Samuel Wilks, Derek J. Smith +1 more

Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial

Clinical Infectious Diseases(2023)10.1093/cid/ciad209

N/A

0DataRank · unranked

23 citations

Nadine Rouphael, Cecilia Losada, Lindsey R. Baden, Evan J. Anderson, Anne F. Luetkemeyer +31 more

Antonia Netzl

Indexed papers

Top data-sharing exemplar

Papers